Research priorities for heart failure with preserved ejection fraction: national heart, lung, and blood institute working group summary

SJ Shah, BA Borlaug, DW Kitzman, AD McCulloch… - Circulation, 2020 - Am Heart Assoc
Heart failure with preserved ejection fraction (HFpEF), a major public health problem that is
rising in prevalence, is associated with high morbidity and mortality and is considered to be …

Nitric oxide signalling in cardiovascular health and disease

C Farah, LYM Michel, JL Balligand - Nature Reviews Cardiology, 2018 - nature.com
Nitric oxide (NO) signalling has pleiotropic roles in biology and a crucial function in
cardiovascular homeostasis. Tremendous knowledge has been accumulated on the …

Phenotype-specific treatment of heart failure with preserved ejection fraction: a multiorgan roadmap

SJ Shah, DW Kitzman, BA Borlaug, L Van Heerebeek… - Circulation, 2016 - Am Heart Assoc
Heart failure (HF) with preserved ejection fraction (EF; HFpEF) accounts for 50% of HF
cases, and its prevalence relative to HF with reduced EF continues to rise. In contrast to HF …

Cardiopulmonary exercise testing: what is its value?

M Guazzi, F Bandera, C Ozemek, D Systrom… - Journal of the American …, 2017 - jacc.org
Compared with traditional exercise tests, cardiopulmonary exercise testing (CPET) provides
a thorough assessment of exercise integrative physiology involving the pulmonary …

Exercise Intolerance in Older Adults With Heart Failure With Preserved Ejection Fraction: JACC State-of-the-Art Review

A Pandey, SJ Shah, J Butler, DL Kellogg Jr… - Journal of the American …, 2021 - jacc.org
Exercise intolerance (EI) is the primary manifestation of chronic heart failure with preserved
ejection fraction (HFpEF), the most common form of heart failure among older individuals …

Heart failure: diagnosis, management and utilization

AA Inamdar, AC Inamdar - Journal of clinical medicine, 2016 - mdpi.com
Despite the advancement in medicine, management of heart failure (HF), which usually
presents as a disease syndrome, has been a challenge to healthcare providers. This is …

Heart failure with preserved ejection fraction: from mechanisms to therapies

CSP Lam, AA Voors, RA de Boer… - European heart …, 2018 - academic.oup.com
This review aims to provide a translational perspective on recent developments in heart
failure with preserved ejection fraction (HFpEF), linking mechanistic insights to potential …

Metabolic effects of dietary nitrate in health and disease

JO Lundberg, M Carlström, E Weitzberg - Cell metabolism, 2018 - cell.com
Nitric oxide (NO), generated from L-arginine and oxygen by NO synthases, is a pleiotropic
signaling molecule involved in cardiovascular and metabolic regulation. More recently, an …

The role of ventricular–arterial coupling in cardiac disease and heart failure: assessment, clinical implications and therapeutic interventions. A consensus document of …

I Ikonomidis, V Aboyans, J Blacher… - European journal of …, 2019 - Wiley Online Library
Ventricular–arterial coupling (VAC) plays a major role in the physiology of cardiac and aortic
mechanics, as well as in the pathophysiology of cardiac disease. VAC assessment …

Isosorbide mononitrate in heart failure with preserved ejection fraction

MM Redfield, KJ Anstrom, JA Levine… - … England Journal of …, 2015 - Mass Medical Soc
Background Nitrates are commonly prescribed to enhance activity tolerance in patients with
heart failure and a preserved ejection fraction. We compared the effect of isosorbide …